Ceruloplasmin is an iron-export ferroxidase that is abundant in plasma and also expressed in glia.
Introduction
Iron accumulation in the substantia nigra (SN) is a feature of Parkinson's disease (PD) 1, 2 , where the iron burden could cause oxidative stress 3 and contribute to Lewy body pathology 4, 5 .
Iron chelation, by drugs such as deferiprone 6 , is a prominent therapeutic strategy for PD. Nigral iron accumulation could be contributed by a disturbance of iron export. The multi-copper ferroxidase, ceruloplasmin, facilitates cellular iron export by oxidizing Fe 2+ presented by ferroportin at the cell surface for incorporation into the extracellular iron transporter, transferrin 7 .
Within the brain, ceruloplasmin is expressed in glia 8 , and we characterized the β-amyloid precursor protein (APP) as the ferroxidase of neurons 9 . We showed recently that tau protein, required for trafficking of APP to the neuronal surface, is decreased in the nigra in PD 2 , and could contribute to pathogenic iron elevation in neurons 1 . The cause of iron elevation in nigral glia in PD 1 is unknown.
Despite not being expressed in neurons 8 , functional depletion of ceruloplasmin causes neurodegeneration. Aceruloplasminemia, an autosomal recessive disorder where mutations abolish functional ceruloplasmin, commonly present with variegated neurological phenotypes including parkinsonism, cognitive loss, cerebellar and retinal degeneration 10 . Carrying one mutant ceruloplasmin allele increases the risk for PD 11 . Analogously, ceruloplasmin knockout (CP -/-6 communication between brain and peripheral pools of ceruloplasmin might be a portal for treatment by peripheral infusion of ceruloplasmin.
Methods

Human brain
Post-mortem brain tissue was obtained from the Victorian Brain Bank Network. Tissue from 10 control individuals (5 male, 76.6 +/-2.1 years) and 10 age-matched patients with clinically and pathologically defined PD (6 male, 75 +/-2.0 years; Supplementary Table 1 ) was homogenized by pulse sonication in PBS with protease inhibitors (Pierce) and phosphatase inhibitor cocktails 1&2 (Sigma).
Mice
At the conclusion of each experiment below, mice were transcardially perfused with ice-cold PBS under deep anaesthesia (sodium pentobarbitone, 100mg/kg).
Deferiprone treatment: Deferiprone (Sigma Medical) was administered in drinking water of 3-months-old CP -/-mice (1 mg/ml) for three months; these were compared to age-matched untreated CP -/-and WTs. Mice on average drank 3 ml of deferiprone-water per day; the dose of deferiprone ingested was approximately 100 mg/kg/day. Before death, mice underwent Rotarod,
Open Field, and Y-maze tasks (Supplementary Methods). Left SN was dissected for biochemical analysis, and right SN was sectioned for stereology.
MPTP: C57/Bl6 administered MPTP (4x10mg/kg, IP, 2 hours apart), were euthanized after 21
days. Micro-dissected SN was homogenized as above.
Ceruloplasmin treatment to CP -/-mice: Human ceruloplasmin (Vital products) was administered 7 to CP -/-mice (5mg/kg in saline, I.P.) and separate groups of mice were euthanized at time-points indicated. Whole brains were homogenized as above.
MPTP rescue with ceruloplasmin: Two groups of 3-month-old C57/Bl6 mice were administered MPTP (as above) and a third group of untreated mice was used as controls. One group received ceruloplasmin protein (5mg/kg in saline, IP) 24 hours and 48 hours after MPTP, then every third day thereafter. The second MPTP-group was administered saline. Mice were euthanized 21 days after MPTP. Left SN was homogenized as above, and right SN was sectioned for stereology.
Ceruloplasmin ferroxidase activity (whole tissue homogenate)
Samples were assayed using established protocols 9 . The ceruloplasmin ferroxidase assay, which we adapt to PD tissue, was first described in 1966 (Osaki et al, JBC, 1996) . The assay requires iron, apo-transferrin and holo-ceruloplasmin (copper loaded); oxygen is also consumed in the reaction. The premise of the assay is that when the added ferrous iron is oxidized by ceruloplasmin, the ferric iron species is then able to load into transferrin, which causes a color change with peak absorbance of 460nm. Ceruloplasmin is selectively inhibited by sodium azide (Osaki et al, JBC, 1996) . The experiment is performed in duplicate: +/-20 mM sodium azide (Sigma). Oxidation by ceruloplasmin in the sample is calculated by subtracting the azide inhibited reading from the original sample reading. A sample blank is also subtracted from both readings to control for background oxidation of ferrous iron. To prepare the brain samples, Triton X-100 (0.1%) was added to PBS homogenized samples, and the soluble fraction was taken after ultracentrifugation (100,000g for 30 minutes at 4 o C). Samples of soluble extract (30 µg protein) were incubated (5 min, 37°C with agitation) with 75 mM sodium acetate pH 6.0, 55 µM apo-transferrin (Sigma), 110 µM ferrous ammonium sulfate (Sigma) ± 20 mM sodium azide (Sigma), before absorbance was measured in a 1 ml cuvette (460 nm). ceruloplasmin was determined by subtracting the ferroxidase signal of the sample aliquot that had ceruloplasmin immunodepleted from the sample aliquot that was not exposed to ceruloplasmin immunodepletion (sham immunodepleted).
Additional Methods
Detailed methodology is described in the Supplementary Methods.
Results
Decreased nigral ceruloplasmin activity accompanies iron accumulation in Parkinson's Disease
Relative to levels from age-matched control samples (n=10), PD-affected SN tissue (n=10) exhibited iron elevation (+42%, P=0.021) and decreased copper (-51%, P=0.003; Fig. 1A ).
9
Despite no change in ceruloplasmin protein levels in PD SN, ceruloplasmin activity (as determined by change in signal upon azide inhibition) was markedly decreased (-80%, P<0.001; Fig. 3 ).
MPTP decreases nigral ceruloplasmin levels
We investigated changes in nigral ceruloplasmin and metals in the MPTP model of PD (Fig.   3A) . Compared to controls (n=10), MPTP-treated mice (n=8) exhibited elevated iron (+21%, P=0.007) and copper (+19%, P=0.026), accompanying decreased ceruloplasmin levels (-45%,
P=0.005) and activity (-60%, P<0.001).
Peripherally administered ceruloplasmin enters brain where it confers neuroprotection
We hypothesized the loss of ceruloplasmin levels after MPTP could contribute to irondependent SN neuronal loss. So we investigated if brain-depletion of ceruloplasmin could be offset by peripheral ceruloplasmin administration and, in turn, rescue the phenotype. CP -/-mice were analyzed for ceruloplasmin entry into perfused brain tissue at intervals over 4 days (n=3 per group) after 5mg/kg protein was injected (I.P.). Ceruloplasmin entered the brain with peak protein levels occurring after 24 hours (Fig. 3B) 
Discussion
We provide evidence that the well-documented, moderate decrease of CSF and circulating ceruloplasmin activity in idiopathic PD [13] [14] [15] [16] [17] [18] [19] may be a reflection of a profound (~80%) loss of ceruloplasmin activity in the SN (Fig. 1A,B) . Loss of ceruloplasmin activity in SN is important because ceruloplasmin deficiency in CP -/-mice causes SN neurodegeneration 12 ( Fig. 2D,E) through loss of iron homeostasis (Fig. 2C) and may be the cause of neurodegeneration in aceruloplasminemia 11 . Furthermore, the elevation of nigral iron in the MPTP model of PD could also be contributed by a marked decrease in ceruloplasmin activity (Fig. 3A) .
We found that the specific activity, but not protein levels of ceruloplasmin is decreased in PD SN (Fig. 1A,B) . Decreased nigral copper (Fig. 1A) , which is required for ceruloplasmin enzyme 12 activity 7 , is one possible explanation. Alternatively, oxidatively-damaged ceruloplasmin causes copper release and loss of ferroxidase activity in PD CSF 15 .
Nigral neurodegeneration in CP -/-mice was attenuated by iron chelation with deferiprone (Fig. 2) . Indeed, deferiprone and other iron chelators protect against PD models 6, 23 , and deferiprone is currently being tested in a phase II clinical trial for PD (ClinicalTrials.gov identifier: NCT00943748). However, deferiprone and other currently available iron chelators were developed to treat peripheral iron overload, and so off-target iron depletion may be a problem in the treatment of brain disorders. We found that peripheral administration of ceruloplasmin attenuated nigral damage in the MPTP mouse model of PD (Fig. 3E-G) , which demonstrated target selectivity by lowering iron in the MPTP-affected SN (Fig. 3C) but not liver (Fig. 3D) .
Previous work has shown that ceruloplasmin activity in PD serum is inversely associated with iron deposition in SN 16, 19, 20 , and low serum CP level is a risk factor for PD 17, 19, 20 . We found that peripheral ceruloplasmin is in communication with the brain and can cross the blood brain barrier (Fig. 3B) . Therefore, the decrease in peripheral ceruloplasmin that occurs in PD may contribute to pathogenesis, or may be a surrogate marker for nigral ceruloplasmin activity (Fig   1A,B) . Supplementation of peripheral ceruloplasmin to normal mice was effective in attenuating nigral pathology in the MPTP model (Fig. 3E-G 
02). (B)
Performance of mice on the accelerating rotarod was studied by Kaplan-Meier survival analysis.
Mantel-cox pairwise comparisons demonstrated that non-treated CP -/-mice had reduced speed survival (P=0.025), which was restored by deferiprone (P=0.05). (C) The right SN was assayed 
Stereological estimation of nigral neurons
Nissl-stained substantia nigra pars compactor (SNpc) neurons were counted by blinded and unbiased stereology. The left SN was removed for estimation of nigral neuron number using by blinded and unbiased stereology using our previously described methods [1] [2] [3] [4] [5] [6] . Briefly, the midbrain was micro-dissected and then cut (30 µm) in 1:3 series with a cryostat, then stained with neutral red (Grale Scientific, Victoria, Australia). The neurons in the SNpc were counted according to the optical fractionator rules, and the neurons in the SNpc were distinguished by the anatomical location, orientation, presence of nucleolus and cell density.
Neuron numbers were estimated using an unbiased counting frame of x=35 µm, y = 45 µm 
Lateral ventricular area and cortical thickness
The left hemisphere was sectioned through the forebrain (30mm) and sections were stained with Nissel. Using the anterior commissure as a landmark, the cortical thickness and lateral ventricular area were measured using ImageJ software, as per our previous study 7 .
Western blot Sample homogenate was separated by 4-12% bis-tris gels (Invitrogen) and electroblotted on a nitrocellulose membrane (iBlot; Invitrogen). Ceruloplasmin antibody (Vital diagnostics) was imaged by enhanced chemiluminescence (GE Healthcare) and scanned with Fujifilm LAS-3000. Membranes were re-probed with -actin antibody (Sigma).
Dopamine measurement
The right striatum of mice was microdissected for dopamine analysis. This tissue homogenised by pulse sonication in 300µl of 0.4M perchloric acid (Sigma Aldrich), 0.15% sodium metabisulphite (Sigma Aldrich), and 0.05% Ethylenediaminetetra acetic acid disodium salt (EDTA) (Sigma Aldrich). The homogenates were centrifuged and the supernatant collected for dopamine measurement with HPLC coupled to an electrochemical detection system (ESA Coulochem III). Briefly, 20µl supernatant samples were injected onto a MD-150 reverse phase C18 column. The system was equilibrated at 0.6 ml/min with the mobile phase consisting of 75mM sodium dihydrogen phosphate, monohydrate (Sigma),
1.7mM 1-Octanesulfonic Acid sodium salt (Sigma), 100µl/l Triethylamine, 25µM EDTA (Sigma) in 10% acetonitrile, pH 3. Compounds were detected and quantified with an electrochemical detector with a conditioning cell (E1:-150mV, E2:+220mV, and guard cell: +250mV). Peaks were identified by the retention time of a dopamine standard (Aigma). Data were normalised to total wet weight of sample.
Atomic absorption spectroscopy (AAS)
Homogenized tissue was lyophilised, digested (69% nitric acid, 30% hydrogen peroxide), then metal assayed by a Varian AA240 AAS. Triplicate measurements were standardized to wet weight.
Statistics
Statistical analysis was performed with SPSS software. Details can be found throughout the text.
